PubHawk
Clin Transl Med February 2023 PMID 36772945

Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.

Shaoquan Zheng, Jie-Ying Liang, Yuhui Tang, Jindong Xie, Yutian Zou, Anli Yang, Nan Shao, Xiaying Kuang, Fei Ji, Xuefeng Liu, Wenwen Tian, Weikai Xiao, Ying Lin

Download social card

Mentions

3
Peak: 2 in Feb 2023
across 2 sources since Feb 2023

Extended reach

3,390
potential audience

Total likes

2

Video views

12

Mentions per month

Feb 2023 – May 2023

Where it's discussed

  • X / Twitter2 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions mention the role of CAFs and biglycan, but the tone is somewhat reserved, with references like 'dissecting the role' and a brief expression of intrigue, reflecting a moderate level of engagement and interest without strong agreement or perceived impact.

AgreementNeither agree nor disagree

The discussions show mixed opinions; some express recognition of the study’s importance, while others seem neutral or unsure.

InterestModerate interest

There is a mild level of curiosity or attention, as the discussions involve scientific terms and potential relevance, but lack enthusiasm.

EngagementNeutral engagement

Participants minimally dissect the content, with some recognition but no deep dives or detailed analyses evident.

ImpactNeutral impact

The overall conversations do not indicate a significant influence or transformative perception of the study; the focus appears somewhat superficial.

Abstract in brief

  • Cancer-associated fibroblasts (CAFs) play a significant role in the response to immunotherapy, but the mechanisms behind their influence on treatment resistance remain underexplored in real-world scenarios.
  • The study combines data from various cancer patient cohorts to investigate CAFs and specifically examines biglycan (BGN), a protein linked to tumor behavior, in relation to immunotherapy outcomes.
  • Results show that CAFs interact closely with immune cells, and higher levels of BGN correlate with poor survival and less favorable immunotherapy responses, indicating its potential as a negative prognostic marker.
Read the full abstract

Top posts

Most liked on X and Bluesky
CAF子
@mofuwhiterabbit · X

こんどはﾋﾞｸﾞﾘｶﾝかぁ！ 抗体あったかなぁ https://t.co/l4gVHdnnhW

Feb 12, 2023 · 2 likes · 1,569 followers View post →
Transcriptomes
@transcriptomes · X

Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeut... https://t.co/fEZFPnPBrJ

Feb 12, 2023 · 1,809 followers View post →

All mentions

Transcriptomes
@transcriptomes · X

Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeut... https://t.co/fEZFPnPBrJ

Feb 12, 2023 · 1,809 followers View post →
CAF子
@mofuwhiterabbit · X

こんどはﾋﾞｸﾞﾘｶﾝかぁ！ 抗体あったかなぁ https://t.co/l4gVHdnnhW

Feb 12, 2023 · 2 likes · 1,569 followers View post →